世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

バイオインフォマティクス市場:技術・サービス別(ナレッジマネジメントツール、バイオインフォマティクスプラットフォーム、バイオインフォマティクスサービス)、用途別(メタボロミクス、分子系統学、トランスクリプトミクス、プロテオミクス、ケモインフォマティクス、ゲノミクス、その他)、地域別(医療バイオインフォマティクス、動物バイオインフォマティクス、農業バイオインフォマティクス、その他)、地域別展望 2030年までの世界予測


Bioinformatics Market based on by Technology & Services (Knowledge Management Tools, Bioinformatics Platforms, and Bioinformatics Services), Application (Metabolomics, Molecular Phylogenetics, Transcriptomics, Proteomics, Chemoinformatics, Genomics, and Others), and Sector (Medical Bioinformatics, Animal Bioinformatics, Agriculture Bioinformatics, Academics, and Others), Regional Outlook Global Forecast up to 2030

世界中の多くの政府や企業組織がバイオインフォマティクスに投資している。こうした投資は、バイオインフォマティクス・サービスにおける技術的ブレークスルーをもたらし、その質を高めている。例えば、政府間組... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
IHR Insights
アイエイチアールインサイト
2024年1月3日 US$4,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
280 英語

 

サマリー

世界中の多くの政府や企業組織がバイオインフォマティクスに投資している。こうした投資は、バイオインフォマティクス・サービスにおける技術的ブレークスルーをもたらし、その質を高めている。例えば、政府間組織でありバイオインフォマティクス研究のパイオニアである欧州分子生物学研究所(EMBL)は、2016年にバイオテクノロジー・生物科学研究評議会、英国心臓財団、英国癌研究協会、欧州委員会、欧州分子生物学機構、欧州研究評議会、国立衛生研究所財団、ビル&メリンダ・ゲイツ財団、ヒューマン・フロンティア・サイエンス・プログラム、欧州研究評議会から資金援助を受けている。
NGS技術の進歩により、使い方が簡単で迅速かつ正確なバイオインフォマティクスツールに対する需要が高まっている。実験研究を行う科学者が必ずしもバイオインフォマティシャンとは限らない。そのため、バイオインフォマティクス・プラットフォームを利用するためには、ユーザーフレンドリーなツールの利用が不可欠である。多くのバイオインフォマティクスのアプリケーションは、適切なユーザーインターフェースがないために、かなりのコンピュータースキルを必要とする。
高度な機能と特徴を備えたゲノム機器のコストは、1,000万ドルから2,000万ドルの間である。製薬会社やバイオインフォマティクス企業、研究施設は、このようなシステムを大量に必要とするため、多くのゲノム機器を取得するための財政支出は相当なものになる。中小規模の製薬企業やバイオインファーマティクス企業、研究施設は、複数のゲノム解析にこのような多額の支出をする余裕はない。
調査方法
二次調査で世界のバイオインフォマティクス市場のシナリオを基本的に理解した後、広範な一次調査を実施した。バイオインフォマティクス市場を提供するティア1およびティア2企業の主要メーカー、ディストリビューター、チャネルパートナーのCレベルおよびDレベルのエグゼクティブ、プロダクトマネージャー、マーケティングおよびセールスマネージャー、ならびに学界、研究機関、CROの担当者など、供給側と需要側の業界専門家を対象に多数の一次インタビューを実施した。これらのインタビューは5つの主要地域で実施された:北米、欧州、アジア太平洋地域、その他の地域(中南米、中東、アフリカ)。一次インタビューのうち、供給側と需要側の参加者は、それぞれ約70%と30%に参加した。アンケート、Eメール、オンライン調査、直接面談、電話インタビューなどを用いて、この主要データを収集した。主な参加者のシェアは以下の通りである:

本調査のセグメンテーション範囲は以下の通りです。
技術およびサービスに基づくバイオインフォマティクス市場
- 知識管理ツール
o 一般化された知識管理ツール
o 専門的知識管理ツール
- バイオインフォマティクスプラットフォーム
o 配列解析プラットフォーム
o 配列アライメントプラットフォーム
o 配列操作プラットフォーム
o 構造解析プラットフォーム
o その他
- バイオインフォマティクスサービス
o シークエンスサービス
o データベース管理
o データ解析
その他
アプリケーション別のバイオインフォマティクス市場
- メタボロミクス
- 分子系統学
- トランスクリプトミクス
- プロテオミクス
- ケモインフォマティクス&ドラッグデザイン
- ゲノミクス
- その他
分野別バイオインフォマティクス市場
- 医療バイオインフォマティクス
- 動物バイオインフォマティクス
- 農業バイオインフォマティクス
- 学術
- その他
バイオインフォマティクス市場:地域別
- 北米
米国
カナダ
- ヨーロッパ
o ドイツ
o イギリス
o フランス
o イタリア
o スペイン
o 残りのヨーロッパ(RoE)
- アジア太平洋(APAC)
o 中国
o 日本
o インド
o オーストラリア
o 韓国
o その他のアジア太平洋地域(RoAPAC)
- ラテンアメリカ(LATAM)
o ブラジル
o アルゼンチン
o その他の南米地域
- 中東・アフリカ(MEA)
o アラブ首長国連邦
o トルコ
o サウジアラビア
o 南アフリカ
o その他の中東・アフリカ
バイオインフォマティクスは、生物学と情報技術を融合させた分野である。バイオインフォマティクスは、生物学と情報技術を融合させた分野であり、生物学的データと情報収集・発信・評価手法とを結びつけ、生物医学をはじめとする幅広い科学研究用途をサポートする。データベース作成、データ管理、ウェアハウス、マイニングのために様々なソフトウェアツールを利用する。データマイニングは、遺伝学やゲノム研究に利用できる科学的洞察を生み出す。コンピュータ・プログラミング、ビッグデータ、生物学を組み合わせたバイオインフォマティクスは、科学者が生物学的データを解釈し、パターンを見つけるのに役立つ。大量のデータを整理するのに役立つため、ゲノム研究やDNA配列決定において有用である。バイオインフォマティクスのツールはいくつか市販されている。これらには、タンパク質の機能解析、相同性・類似性解析、配列解析などのツールが含まれる。
世界のバイオインフォマティクス事業は、統合データへのニーズの高まりとプロテオミクスおよびゲノミクスの拡大により、今後大幅に増加すると予想される。さらに、創薬と医薬品開発は、予測期間を通じて市場の成長を促進すると予想される。しかし、有資格の専門家や共通のデータフォーマットの不足が、予測期間中の市場成長を阻害すると予測される。対照的に、市場参加者は統合ソリューションやシステムに対する需要の増加から恩恵を受けると予想される。
バイオインフォマティクス市場は、ナレッジ・マネジメント・ツール、バイオインフォマティクス・プラットフォーム、バイオインフォマティクス・サービスの3つのカテゴリーに分類される。バイオインフォマティクス・プラットフォームのカテゴリーは、2019年に最も収益に貢献し、この傾向は、プラットフォーム・アプリケーションの成長と医薬品開発におけるより良いツールの需要により、予測期間中も続くと予想される。プラットフォームアプリケーションの増加は、構造同定と改変に対するライフサイエンス企業からの需要の増加に起因している。その結果、投薬設計プロセスや治療効果の評価に役立つことになる。さらに、医薬品の研究・発見における効率性と安全性が向上するにつれて、より優れた医薬品開発ツールの必要性が高まっている。その結果、バイオインフォマティクス市場は今後成長する可能性が高い。
バイオインフォマティクス市場は、メタボロミクス、分子系統学、トランスクリプトミクス、プロテオミクス、ケモインフォマティクス&ドラッグデザイン、ゲノミクス、その他のアプリケーションに分類される。トランスクリプトミクスのカテゴリーは、コンパニオン診断と個別化治療薬の需要増加により、予測期間を通じて最も拡大すると予想される。さらに、革新的な遺伝子配列決定、進行中のバイオマーカー開発、トランスクリプトミクス技術の世界的な受容が、バイオインフォマティクス産業の成長を促進すると予測されている。
バイオインフォマティクス市場は4つの地域に分けられる:北米、欧州、アジア太平洋、中南米である。2019年は北米が市場をリードし、最大のシェアを占め、この傾向は予測期間を通じて続くと予測される。この背景には、洗練された技術の利用が増加していることに加え、医薬品の研究開発プロセスに不可欠なバイオインフォマティクスツールの改善ニーズが高まっていることがある。ゲノミクスとプロテオミクスの画期的な進歩により、評価・処理しなければならない膨大な量のデータが生成されるため、LAMEAの市場は予測期間中に最も速いCAGRで拡大すると予測される。さらに、この地域ではバイオインフォマティクス産業はまだ黎明期にあり、研究活動は徐々に拡大している。
世界のバイオインフォマティクス産業で事業を展開する主要企業、すなわち、Agilent Technologies, Inc.、Biomax Informatics AG、DNAnexus, Inc.、Genedata AG、Intrexon Bioinformatics Germany GmbH、Illumina Inc.、Perkinelmer Inc.、Qiagen N.V.、Seven Bridges Genomics Inc.、Thermo Fisher Scientific, Inc.バリューチェーンの他のプレーヤーには、Geneva Bioinformatics (Genebio)、Dassault Systems、Eurofins Scientific、Bruker Daltonics Inc.、Accelrys, Inc.、Affymetrix, Inc.、SA Nonlinear Dynamics、Quest Diagnostics, Inc.が含まれる。
- 本レポートは、バイオインフォマティクス市場の最も重要な属性を示しています。
- この調査レポートは、バイオインフォマティクス市場の成長を市場のいくつかのセグメントに基づいて詳細に分析します。
- バイオインフォマティクス市場の過去と現在の動向予測を提示します。
- また、バイオインフォマティクス市場の主要企業の主要戦略や能力などの競争分析を紹介します。

ページTOPに戻る


目次

Table of Contents
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Technology and services: Market Size & Analysis
5.1. Overview
5.2. Knowledge Management Tools
5.2.1. Generalized Knowledge Management Tools
5.2.2. Specialized Knowledge Management Tools
5.3. Bioinformatics Platforms
5.3.1. Sequence Analysis Platforms
5.3.2. Sequence Alignment Platforms
5.3.3. Sequence Manipulation Platforms
5.3.4. Structural Analysis Platforms
5.3.5. Others
5.4. Bioinformatics Services
5.4.1. Sequencing Services
5.4.2. Database Management
5.4.3. Data Analysis
5.5. Others
6. Application: Market Size & Analysis
6.1. Overview
6.2. Metabolomics
6.3. Molecular Phylogenetics
6.4. Transcriptomics
6.5. Proteomics
6.6. Chemoinformatics & Drug design
6.7. Genomics
6.8. Others
7. Sector: Market Size & Analysis
7.1. Overview
7.2. Medical Bioinformatics
7.3. Animal Bioinformatics
7.4. Agriculture Bioinformatics
7.5. Academics
7.6. Others
8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America (U.S., Mexico, Canada)
8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
8.5. Latin America (Brazil, Argentina)
8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
10.1. THERMO FISHER SCIENTIFIC, INC.
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. SEVEN BRIDGES GENOMICS INC.
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. DNANEXUS, INC.
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. QIAGEN N.V.
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. INTREXON BIOINFORMATICS GERMANY GMBH
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. GENEDATA AG
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. PERKINELMER, INC.
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. BIOMAX INFORMATICS AG
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. AGILENT TECHNOLOGIES, INC.
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. ILLUMINA, INC.
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy

11. Analyst Opinion
12. Annexure
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations

ページTOPに戻る



図表リスト

Tables
TABLE 1. BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 2. BIOINFORMATICS MARKET VALUE FOR KNOWLEDGE MANAGEMENT TOOLS, BY GEOGRAPHY , 2021-2030 (USD BILLION)
TABLE 3. BIOINFORMATICS MARKET VALUE FOR BIOINFORMATICS PLATFORMS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. BIOINFORMATICS MARKET VALUE FOR BIOINFORMATICS SERVICES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 6. BIOINFORMATICS MARKET VALUE FOR METABOLOMICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. BIOINFORMATICS MARKET VALUE FOR TRANSCRIPTOMICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 8. BIOINFORMATICS MARKET VALUE FOR PROTEOMICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 9. BIOINFORMATICS MARKET VALUE FOR CHEMOINFORMATICS & DRUG DESIGN, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 10. BIOINFORMATICS MARKET VALUE FOR GENOMICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 11. BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 12. BIOINFORMATICS MARKET VALUE FOR ANIMAL BIOINFORMATICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 13. BIOINFORMATICS MARKET VALUE FOR MEDICAL BIOINFORMATICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 14. BIOINFORMATICS MARKET VALUE FOR AGRICULTURE BIOINFORMATICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 15. BIOINFORMATICS MARKET VALUE FOR ACADEMICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 16. BIOINFORMATICS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 17. NORTH AMERICA BIOINFORMATICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 18. NORTH AMERICA BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 19. NORTH AMERICA BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 20. NORTH AMERICA BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 21. U.S BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 22. U.S BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 23. U.S BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 24. CANADA BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 25. CANADA BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 26. CANADA BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 27. MEXICO BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 28. MEXICO BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 29. MEXICO BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 30. EUROPE BIOINFORMATICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 31. EUROPE BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 32. EUROPE BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 33. EUROPE BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 34. GERMANY BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 35. GERMANY BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 36. GERMANY BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 37. U.K BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 38. U.K BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 39. U.K BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 40. FRANCE BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 41. FRANCE BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 42. FRANCE BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 43. ITALY BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 44. ITALY BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 45. ITALY BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 46. SPAIN BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 47. SPAIN BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 48. SPAIN BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 49. ROE BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 50. ROE BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 51. ROE BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 52. ASIA PACIFIC BIOINFORMATICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 53. ASIA PACIFIC BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 54. ASIA PACIFIC BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 55. ASIA PACIFIC BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 56. CHINA BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 57. CHINA BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 58. CHINA BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 59. INDIA BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 60. INDIA BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 61. INDIA BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 62. JAPAN BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 63. JAPAN BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 64. JAPAN BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 65. REST OF APAC BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 66. REST OF APAC BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 67. REST OF APAC BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 68. LATIN AMERICA BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 69. LATIN AMERICA BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 70. LATIN AMERICA BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 71. BRAZIL BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 72. BRAZIL BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 73. BRAZIL BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 74. ARGENTINA BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 75. ARGENTINA BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 76. ARGENTINA BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 77. MIDDLE EAST AND AFRICA BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 78. MIDDLE EAST AND AFRICA BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 79. MIDDLE EAST AND AFRICA BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 80. SAUDI ARABIA BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 81. SAUDI ARABIA BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 82. SAUDI ARABIA BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 83. UAE BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 84. UAE BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 85. UAE BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 86. REST OF MIDDLE EAST AND AFRICA BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 87. REST OF MIDDLE EAST AND AFRICA BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 88. REST OF MIDDLE EAST AND AFRICA BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 89. THERMO FISHER SCIENTIFIC, INC. : FINANCIALS
TABLE 90. THERMO FISHER SCIENTIFIC, INC. : PRODUCTS & SERVICES
TABLE 91. THERMO FISHER SCIENTIFIC, INC. : RECENT DEVELOPMENTS
TABLE 92. SEVEN BRIDGES GENOMICS INC.: FINANCIALS
TABLE 93. SEVEN BRIDGES GENOMICS INC.: PRODUCTS & SERVICES
TABLE 94. SEVEN BRIDGES GENOMICS INC.: RECENT DEVELOPMENTS
TABLE 95. DNANEXUS, INC.: FINANCIALS
TABLE 96. DNANEXUS, INC.: PRODUCTS & SERVICES
TABLE 97. DNANEXUS, INC.: RECENT DEVELOPMENTS
TABLE 98. QIAGEN N.V.: FINANCIALS
TABLE 99. QIAGEN N.V.: PRODUCTS & SERVICES
TABLE 100. QIAGEN N.V.: RECENT DEVELOPMENTS
TABLE 101. INTREXON BIOINFORMATICS GERMANY GMBH: FINANCIALS
TABLE 102. INTREXON BIOINFORMATICS GERMANY GMBH: PRODUCTS & SERVICES
TABLE 103. INTREXON BIOINFORMATICS GERMANY GMBH: RECENT DEVELOPMENTS
TABLE 104. GENEDATA AG: FINANCIALS
TABLE 105. GENEDATA AG: PRODUCTS & SERVICES
TABLE 106. GENEDATA AG: RECENT DEVELOPMENTS
TABLE 107. PERKINELMER, INC.: FINANCIALS
TABLE 108. PERKINELMER, INC.: PRODUCTS & SERVICES
TABLE 109. PERKINELMER, INC.: DEVELOPMENTS
TABLE 110. BIOMAX INFORMATICS AG: FINANCIALS
TABLE 111. BIOMAX INFORMATICS AG: PRODUCTS & SERVICES
TABLE 112. BIOMAX INFORMATICS AG: RECENT DEVELOPMENTS
TABLE 113. AGILENT TECHNOLOGIES, INC.: FINANCIALS
TABLE 114. AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES
TABLE 115. AGILENT TECHNOLOGIES, INC.: RECENT DEVELOPMENTS
TABLE 116. ILLUMINA, INC.: FINANCIALS
TABLE 117. ILLUMINA, INC.: PRODUCTS & SERVICES
TABLE 118. ILLUMINA, INC.: RECENT DEVELOPMENTS

 

ページTOPに戻る


 

Summary

Many governments and business organisations throughout the world are investing in bioinformatics. These expenditures have resulted in technical breakthroughs in bioinformatics services, which have increased their quality. For example, the European Molecular Biology Laboratory (EMBL), an intergovernmental organisation and pioneer in bioinformatics research, received funding in 2016 from the Biotechnology and Biological Sciences Research Council, the British Heart Foundation, Cancer Research UK, the European Commission, the European Molecular Biology Organisation, the European Research Council, the Foundation of the National Institutes of Health, the Bill & Melinda Gates Foundation, the Human Frontier Science Programme, and the European Research Council.
Advances in NGS technology have increased the demand for speedy and accurate bioinformatics tools that are simple to use. Scientists that do experimental research are not always bioinformaticians. As a result, the availability of user-friendly tools is critical for using bioinformatics platforms. Many bioinformatics applications need considerable computer skills, owing to a lack of a suitable user interface.
The cost of genomic equipment with advanced features and functionality ranges between USD 10 and 20 million. Because pharmaceutical and bioinfirmatics firms and research facilities require a large number of such systems, their financial outlay for acquiring many genomic instruments is substantial. Small and medium-sized pharmaceutical and bioinfirmatics enterprises, as well as research facilities, cannot afford to make such large expenditures in multiple genomics.
Research Methodology:
After secondary research provided a fundamental understanding of the worldwide Bioinformatics Market scenario, extensive primary research was carried out. A number of primary interviews were carried out with industry experts from the supply and demand sides, including C- and D-level executives, product managers, and marketing and sales managers of major manufacturers, distributors, and channel partners from tier 1 and tier 2 companies offering Bioinformatics Market, as well as personnel from academia, research, and CROs. These interviews were conducted across five major regions: North America, Europe, Asia Pacific, and the Rest of the World (Latin America & the Middle East & Africa). Participants from the supply-side and demand-side participated in about 70% and 30% of the primary interviews, respectively. Through the use of questionnaires, emails, online surveys, in-person interviews, and phone interviews, this main data was gathered. The primary participants share is given below:

The segmentation coverage of the study is provided below.
Bioinformatics Market based on Technology and Services:
• Knowledge Management Tools
o Generalized Knowledge Management Tools
o Specialized Knowledge Management Tools
• Bioinformatics Platforms
o Sequence Analysis Platforms
o Sequence Alignment Platforms
o Sequence Manipulation Platforms
o Structural Analysis Platforms
o Others
• Bioinformatics Services
o Sequencing Services
o Database Management
o Data Analysis
o Others
Bioinformatics Market based on Application:
• Metabolomics
• Molecular Phylogenetics
• Transcriptomics
• Proteomics
• Chemoinformatics & Drug design
• Genomics
• Others
Bioinformatics Market based on Sector:
• Medical Bioinformatics
• Animal Bioinformatics
• Agriculture Bioinformatics
• Academics
• Others
Bioinformatics Market based on Geography:
• North America
o US
o Canada
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe (RoE)
• Asia Pacific (APAC)
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific (RoAPAC)
• Latin America (LATAM)
o Brazil
o Argentina
o Rest of South America
• Middle East and Africa (MEA)
o UAE
o Turkey
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
Bioinformatics is a field that merges biology and information technology. It links biological data with information gathering, dissemination, and assessment methods to support a wide range of scientific research applications, including biomedicine. It makes use of a variety of software tools for database creation, data administration, warehousing, and mining. Data mining generates scientific insights that may be used to genetics and genomic research. Bioinformatics, which combines computer programming, big data, and biology, helps scientists to interpret and find patterns in biological data. It is useful in genome research and DNA sequencing because it helps scientists to organise massive volumes of data. There are several bioinformatics tools available on the market. These include tools for protein functional and analysis, homology and similarity, sequence analysis, and others.
The global bioinformatics business is expected to increase significantly in the future due to the increasing need for integrated data and the expansion of proteomics and genomics. Furthermore, drug discovery and development are expected to drive market growth throughout the forecast period. However, a lack of qualified professionals and common data formats is projected to stymie market growth over the projection period. In contrast, market participants are expected to benefit from increased demand for integrated solutions and systems.
The bioinformatics market is divided into three categories: knowledge management tools, bioinformatics platforms, and bioinformatics services. The bioinformatics platforms category contributed the most revenue in 2019, and this trend is expected to continue during the projection period, owing to a growth in platform applications and a demand for better tools in drug development. The rise in platform application can be ascribed to an increase in demand from life science firms for structural identification and modification. This, in turn, would aid in the medication design process and the evaluation of therapeutic effects. Furthermore, the need for better drug development tools grows as efficiency and safety in drug research and discovery improve. As a result, the bioinformatics market is likely to grow in the future.
The bioinformatics market is divided into applications such as metabolomics, molecular phylogenetics, transcriptomics, proteomics, chemoinformatics & drug design, genomics, and others. The transcriptomics category is expected to expand the most throughout the forecast period, owing to an increase in demand for companion diagnostics and personalised therapeutics. Furthermore, innovative gene sequencing, ongoing biomarker development, and global acceptance of transcriptomics technology are projected to fuel bioinformatics industry growth.
The bioinformatics market is divided into four regions: North America, Europe, Asia-Pacific, and Latin America. North America led the market in 2019, accounting for the largest share, and this trend is expected to continue throughout the forecast period. This is due to a growth in the use of sophisticated technology as well as an increase in the need for improved bioinformatics tools, which are essential in the drug research and development process. Because of breakthroughs in genomics and proteomics, which generate huge amounts of data that must be evaluated and handled, the market in LAMEA is predicted to expand at the fastest CAGR over the forecast period. Furthermore, the bioinformatics industry is still in its infancy in the region, where research activities are progressively expanding.
The key players operating in the global bioinformatics industry, namely, Agilent Technologies, Inc., Biomax Informatics AG, DNAnexus, Inc., Genedata AG, Intrexon Bioinformatics Germany GmbH, Illumina Inc., Perkinelmer Inc., Qiagen N.V., Seven Bridges Genomics Inc., and Thermo Fisher Scientific, Inc. The other players in the value chain include Geneva Bioinformatics (Genebio), Dassault Systems, Eurofins Scientific, Bruker Daltonics Inc., Accelrys, Inc., Affymetrix, Inc., SA Nonlinear Dynamics, and Quest Diagnostics, Inc.
• This report illustrates the most vital attributes of the Bioinformatics Market, which are driving and providing opportunities.
• This research gives an in-depth analysis of the Bioinformatics Market growth on the basis of several segments in the market.
• This report presents the predictions of the past and present trends of the Bioinformatics Market.
• This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Bioinformatics Market.



ページTOPに戻る


Table of Contents

Table of Contents
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Technology and services: Market Size & Analysis
5.1. Overview
5.2. Knowledge Management Tools
5.2.1. Generalized Knowledge Management Tools
5.2.2. Specialized Knowledge Management Tools
5.3. Bioinformatics Platforms
5.3.1. Sequence Analysis Platforms
5.3.2. Sequence Alignment Platforms
5.3.3. Sequence Manipulation Platforms
5.3.4. Structural Analysis Platforms
5.3.5. Others
5.4. Bioinformatics Services
5.4.1. Sequencing Services
5.4.2. Database Management
5.4.3. Data Analysis
5.5. Others
6. Application: Market Size & Analysis
6.1. Overview
6.2. Metabolomics
6.3. Molecular Phylogenetics
6.4. Transcriptomics
6.5. Proteomics
6.6. Chemoinformatics & Drug design
6.7. Genomics
6.8. Others
7. Sector: Market Size & Analysis
7.1. Overview
7.2. Medical Bioinformatics
7.3. Animal Bioinformatics
7.4. Agriculture Bioinformatics
7.5. Academics
7.6. Others
8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America (U.S., Mexico, Canada)
8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
8.5. Latin America (Brazil, Argentina)
8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
10.1. THERMO FISHER SCIENTIFIC, INC.
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. SEVEN BRIDGES GENOMICS INC.
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. DNANEXUS, INC.
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. QIAGEN N.V.
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. INTREXON BIOINFORMATICS GERMANY GMBH
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. GENEDATA AG
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. PERKINELMER, INC.
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. BIOMAX INFORMATICS AG
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. AGILENT TECHNOLOGIES, INC.
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. ILLUMINA, INC.
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy

11. Analyst Opinion
12. Annexure
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations

ページTOPに戻る



List of Tables/Graphs

Tables
TABLE 1. BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 2. BIOINFORMATICS MARKET VALUE FOR KNOWLEDGE MANAGEMENT TOOLS, BY GEOGRAPHY , 2021-2030 (USD BILLION)
TABLE 3. BIOINFORMATICS MARKET VALUE FOR BIOINFORMATICS PLATFORMS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. BIOINFORMATICS MARKET VALUE FOR BIOINFORMATICS SERVICES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 6. BIOINFORMATICS MARKET VALUE FOR METABOLOMICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. BIOINFORMATICS MARKET VALUE FOR TRANSCRIPTOMICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 8. BIOINFORMATICS MARKET VALUE FOR PROTEOMICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 9. BIOINFORMATICS MARKET VALUE FOR CHEMOINFORMATICS & DRUG DESIGN, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 10. BIOINFORMATICS MARKET VALUE FOR GENOMICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 11. BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 12. BIOINFORMATICS MARKET VALUE FOR ANIMAL BIOINFORMATICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 13. BIOINFORMATICS MARKET VALUE FOR MEDICAL BIOINFORMATICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 14. BIOINFORMATICS MARKET VALUE FOR AGRICULTURE BIOINFORMATICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 15. BIOINFORMATICS MARKET VALUE FOR ACADEMICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 16. BIOINFORMATICS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 17. NORTH AMERICA BIOINFORMATICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 18. NORTH AMERICA BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 19. NORTH AMERICA BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 20. NORTH AMERICA BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 21. U.S BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 22. U.S BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 23. U.S BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 24. CANADA BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 25. CANADA BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 26. CANADA BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 27. MEXICO BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 28. MEXICO BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 29. MEXICO BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 30. EUROPE BIOINFORMATICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 31. EUROPE BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 32. EUROPE BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 33. EUROPE BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 34. GERMANY BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 35. GERMANY BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 36. GERMANY BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 37. U.K BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 38. U.K BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 39. U.K BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 40. FRANCE BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 41. FRANCE BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 42. FRANCE BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 43. ITALY BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 44. ITALY BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 45. ITALY BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 46. SPAIN BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 47. SPAIN BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 48. SPAIN BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 49. ROE BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 50. ROE BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 51. ROE BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 52. ASIA PACIFIC BIOINFORMATICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 53. ASIA PACIFIC BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 54. ASIA PACIFIC BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 55. ASIA PACIFIC BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 56. CHINA BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 57. CHINA BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 58. CHINA BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 59. INDIA BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 60. INDIA BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 61. INDIA BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 62. JAPAN BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 63. JAPAN BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 64. JAPAN BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 65. REST OF APAC BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 66. REST OF APAC BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 67. REST OF APAC BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 68. LATIN AMERICA BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 69. LATIN AMERICA BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 70. LATIN AMERICA BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 71. BRAZIL BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 72. BRAZIL BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 73. BRAZIL BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 74. ARGENTINA BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 75. ARGENTINA BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 76. ARGENTINA BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 77. MIDDLE EAST AND AFRICA BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 78. MIDDLE EAST AND AFRICA BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 79. MIDDLE EAST AND AFRICA BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 80. SAUDI ARABIA BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 81. SAUDI ARABIA BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 82. SAUDI ARABIA BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 83. UAE BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 84. UAE BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 85. UAE BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 86. REST OF MIDDLE EAST AND AFRICA BIOINFORMATICS MARKET VALUE, BY TECHNOLOGY AND SERVICES, 2021-2030 (USD BILLION)
TABLE 87. REST OF MIDDLE EAST AND AFRICA BIOINFORMATICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 88. REST OF MIDDLE EAST AND AFRICA BIOINFORMATICS MARKET VALUE, BY SECTOR, 2021-2030 (USD BILLION)
TABLE 89. THERMO FISHER SCIENTIFIC, INC. : FINANCIALS
TABLE 90. THERMO FISHER SCIENTIFIC, INC. : PRODUCTS & SERVICES
TABLE 91. THERMO FISHER SCIENTIFIC, INC. : RECENT DEVELOPMENTS
TABLE 92. SEVEN BRIDGES GENOMICS INC.: FINANCIALS
TABLE 93. SEVEN BRIDGES GENOMICS INC.: PRODUCTS & SERVICES
TABLE 94. SEVEN BRIDGES GENOMICS INC.: RECENT DEVELOPMENTS
TABLE 95. DNANEXUS, INC.: FINANCIALS
TABLE 96. DNANEXUS, INC.: PRODUCTS & SERVICES
TABLE 97. DNANEXUS, INC.: RECENT DEVELOPMENTS
TABLE 98. QIAGEN N.V.: FINANCIALS
TABLE 99. QIAGEN N.V.: PRODUCTS & SERVICES
TABLE 100. QIAGEN N.V.: RECENT DEVELOPMENTS
TABLE 101. INTREXON BIOINFORMATICS GERMANY GMBH: FINANCIALS
TABLE 102. INTREXON BIOINFORMATICS GERMANY GMBH: PRODUCTS & SERVICES
TABLE 103. INTREXON BIOINFORMATICS GERMANY GMBH: RECENT DEVELOPMENTS
TABLE 104. GENEDATA AG: FINANCIALS
TABLE 105. GENEDATA AG: PRODUCTS & SERVICES
TABLE 106. GENEDATA AG: RECENT DEVELOPMENTS
TABLE 107. PERKINELMER, INC.: FINANCIALS
TABLE 108. PERKINELMER, INC.: PRODUCTS & SERVICES
TABLE 109. PERKINELMER, INC.: DEVELOPMENTS
TABLE 110. BIOMAX INFORMATICS AG: FINANCIALS
TABLE 111. BIOMAX INFORMATICS AG: PRODUCTS & SERVICES
TABLE 112. BIOMAX INFORMATICS AG: RECENT DEVELOPMENTS
TABLE 113. AGILENT TECHNOLOGIES, INC.: FINANCIALS
TABLE 114. AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES
TABLE 115. AGILENT TECHNOLOGIES, INC.: RECENT DEVELOPMENTS
TABLE 116. ILLUMINA, INC.: FINANCIALS
TABLE 117. ILLUMINA, INC.: PRODUCTS & SERVICES
TABLE 118. ILLUMINA, INC.: RECENT DEVELOPMENTS

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

IHR Insights社の医療分野での最新刊レポート


よくあるご質問


IHR Insights社はどのような調査会社ですか?


IHR InsightsはICT、化学品、ヘルスケア、半導体など、世界の幅広い分野を対象に調査し、専門的な知識を基に市場調査報告書を出版しています。 主な調査分野 ◇ICT ◇化学品、材料、... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る